Seattle, January 9, 2014 – Alliance of Angels today announced that it has led an oversubscribed seed round of $1.9M into ActX, a biotech startup focused on making actionable patient genomic information truly useful in everyday medical practice. The company was founded by Andrew Ury, a veteran entrepreneur who previously founded Practice Partner, a pioneer in electronic health records that was acquired by McKesson.
“We were blown away by Andrew, the caliber of the team he’s assembled, and his vision for building the next great biotech company in Seattle.” said Yi-Jian Ngo, Managing Director at Alliance of Angels.
“As my fellow entrepreneurs know, fundraising can be a huge drain of time and energy, and I couldn’t be more impressed with the speed and efficiency of Alliance of Angels,” said Andrew Ury, Founder & CEO of ActX. “Within six weeks of engaging, our round was already oversubscribed, plus many of our new investors brought with them a wealth of connections and operating experience that will accelerate our company’s growth.”
Investing more than $10M a year into early stage companies in the Pacific Northwest, Alliance of Angels is one of the most active angel groups in the U.S. Other Alliance of Angels investments in 2013 include Battlefy, Buddy Platform, Brightkit, CollegeMapper, Easy Metrics, Exo Labs, Fanzo, Flowboard, Mobisante, Illumagear, Impel Neuropharma, Indow Windows, Kigo Kitchen, Placefull, Revel Body, Scayl, Simple Verity, Storrage and Valant Medical.
ActX, Inc. is a dynamic venture that is focused on making actionable patient genomic information truly useful in everyday medical practice.
About Alliance of Angels
Alliance of Angels is the premier angel group in the Pacific Northwest, comprising more than 100 investors who fund and mentor early stage companies. It is recognized as one of the most active angel groups in the nation, having invested over $80 million in more than 200 early stage companies since 1997. To learn more, visit www.allianceofangels.com.